BioNTech
- General
BioNTech’s revenues declined by 78% in 2023
BioNTech announced its financial results for the last year and the final quarter through a statement. According to the announcement,…
Read More » - Business
BioNTech announces $209 Million net loss in Q2
Pharmaceutical firm’s revenues drop some 95% year-on-year in 2nd quarter Pharmaceutical company BioNTech announced a net loss of €190.4 million…
Read More » - Business
Turkiye: Koç University, BioNTech to cooperate on cancer research
Germany-based biotechnology company BioNTech and Turkiye’s Koç University have signed a collaboration agreement that encompasses a series of clinical research,…
Read More » - Business
Drug companies face COVID cliff in 2023 as sales set to plummet
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up…
Read More » - Business
Stocks making the biggest moves premarket: Spirit Airlines, BioNTech, Robinhood and more
Spirit Airlines lost 4.7% in the premarket after saying it would accept the latest improved takeover bid from Frontier Group…
Read More » - Business
BioNTech vaccine sales, profit triple in Q1
Company’s quarterly revenues reach €6.3B ($6.7B) in 3-month period that ended on March 31 The German pharma firm BioNTech on…
Read More » - Business
European stocks close lower as ECB meeting nears
Investors focused on Russia-Ukraine war, concerned about impact of inflation and higher interest rates on global economy European stock markets…
Read More » - Business
BioNTech profits jump to $11.5B in 2021, up from $17M in 2020
Germany-based coronavirus vaccine developer and producer BioNTech reported a whopping 10.3 billion euros ($11.5 billion) in profits in 2021, skyrocketing…
Read More » - Business
BioNTech unveils plans for container vaccine factories in Africa
Facilities will be able to make various mRNA-based vaccines, including Pfizer-BioNTech COVID-19 jab, says German firm German pharma firm BioNTech…
Read More » - Business
BioNTech announces $3.7B profit in Q3
Thanks to rapid rise in supply and sales of COVID-19 vaccine, total revenues of BioNTech hit €6.1 billion in July-September…
Read More »